ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PRAN Amundi Prime Em

14.903
0.00 (0.00%)
Last Updated: 12:26:56
Delayed by 15 minutes
Name Symbol Market Type
Amundi Prime Em LSE:PRAN London Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 14.903 14.856 15.064 0 12:26:56

Prana Announces Filing of Annual Report

28/09/2007 4:58pm

PR Newswire (US)


Amundi Prime Em (LSE:PRAN)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Amundi Prime Em Charts.
MELBOURNE, Australia, Sept. 28 /PRNewswire-FirstCall/ -- Prana Biotechnology Limited (NasdaqCM: PRAN) (ASX:PBT.AX), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced it has filed its annual report containing audited consolidated financial statements for the year ended June 30, 2007, with the U.S. Securities and Exchange Commission. The annual report its available on Prana's website (http://www.pranabio.com/). Shareholders may receive a hard copy of the annual report free of charge upon request. About Prana Biotechnology Limited Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related neurodegenerative disorders. The company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology. For further information, please visit our web site at http://www.pranabio.com/. DATASOURCE: Prana Biotechnology Limited CONTACT: Investors, Mark Jones, +1-646-284-9414, ; Media, Ivette Almeida, +1-646-284-9455, Web site: http://www.pranabio.com/

Copyright

1 Year Amundi Prime Em Chart

1 Year Amundi Prime Em Chart

1 Month Amundi Prime Em Chart

1 Month Amundi Prime Em Chart